These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. pH-dependent dissolution rate of nitrofurantoin from commercial suspensions, tablets, and capsules. Bates TR; Young JM; Wu CM; Rosenberg HA J Pharm Sci; 1974 Apr; 63(4):643-5. PubMed ID: 4828728 [No Abstract] [Full Text] [Related]
44. Stability of refrigerated miglustat after preparation in InOrpha(®) flavored suspending excipient for compounding of oral solutions and suspensions. Riahi S; Ambühl M; Stichler J; Bandilla D Drug Des Devel Ther; 2015; 9():561-6. PubMed ID: 25632223 [TBL] [Abstract][Full Text] [Related]
46. [Effect of the production process on the quality of drugs]. Murav'ev IO Farm Zh; 1976; (2):20-7. PubMed ID: 1269692 [No Abstract] [Full Text] [Related]
47. [Optimization of the technology and a biopharmaceutic study of mefenamic acid suppositories]. Golovkin VA; Lukash EP; Fadeicheva AG; Groshovyĭ TA; Mokhort NA Farmatsiia; 1978; 27(4):16-9. PubMed ID: 689174 [No Abstract] [Full Text] [Related]
48. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. Haleblian JK J Pharm Sci; 1975 Aug; 64(8):1269-88. PubMed ID: 1151699 [No Abstract] [Full Text] [Related]
49. DETERMINATION OF ISOMERIC PURITY OF DEXTROAMPHETAMINE IN TABLETS AND CAPSULES. BROCHMANN-HANSSEN E J Pharm Sci; 1964 Oct; 53():1287-8. PubMed ID: 14249470 [No Abstract] [Full Text] [Related]
52. [The consequence of the preparation factors for the effect of the drug]. Johnsgård M; Pedersen AO Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086 [No Abstract] [Full Text] [Related]
53. [Biopharmaceutical aspects of pharmaceutical technology]. Thoma K Pharmazie; 1981 Mar; 36(3):185-93. PubMed ID: 7279982 [No Abstract] [Full Text] [Related]
55. Development of preservative-free nanoparticles-based emulsions: Effects of NP surface properties and sterilization process. Rowenczyk L; Picard C; Duclairoir-Poc C; Hucher N; Orange N; Feuilloley M; Grisel M Int J Pharm; 2016 Aug; 510(1):125-34. PubMed ID: 27286638 [TBL] [Abstract][Full Text] [Related]
56. Degradation studies of azithromycin and its spectrophotometric determination in pharmaceutical dosage forms. Sultana N; Arayne MS; Hussain F; Fatima A Pak J Pharm Sci; 2006 Apr; 19(2):98-103. PubMed ID: 16751118 [TBL] [Abstract][Full Text] [Related]
57. [Soluble tablets for the preparation of eye drops]. Smazyński T; Krówczyński L Acta Pol Pharm; 1968 Jun; 25(3):291-8. PubMed ID: 5680565 [No Abstract] [Full Text] [Related]
58. [Effect of the method of wetting of particles on the rheologic properties and physical stability of sulfamide suspensions]. Moës A Pharm Acta Helv; 1970 Feb; 45(2):101-10. PubMed ID: 5436302 [No Abstract] [Full Text] [Related]
59. [On the stability and time of suitability of chemical-pharmaceutical preparations and ready-made drug forms]. Iaskina DZ; Mishin VP; Gritsenko SV Farmatsiia; 1968; 17(1):81-6. PubMed ID: 4885469 [No Abstract] [Full Text] [Related]